Thermo Fisher Scientific (NY:TMO)

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

3 Low-Volatility Stocks That Fall Short

December 28, 2025

Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, January 29, 2026

December 26, 2025

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Sector Rotation: 2 Smart Money Moves for 2026 ↗

December 26, 2025

Via MarketBeat

2 S&P 500 Stocks Worth Investigating and 1 We Avoid

December 23, 2025

Q3 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

Topics Stocks

December 21, 2025

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Thermo Fisher (NYSE:TMO) and its peers.

Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works...

Topics Economy

3 Mega-Cap Stocks with Warning Signs

December 18, 2025

OlivePoint Capital Acquires 3900 Paramount Parkway in Raleigh–Durham, Expanding Its High-Conviction Office Special Situations Strategy

December 15, 2025

From OlivePoint Capital

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

3 Profitable Stocks Walking a Fine Line

December 14, 2025

Danaher Sweetens the Pot: Board Approves $0.32 Quarterly Cash Dividend, Signaling Robust Financial Health

Topics Economy

December 09, 2025

New York, NY – December 9, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced that its Board of Directors has approved a regular quarterly cash dividend...

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Gapping S&P500 stocks in Thursday's session ↗

December 04, 2025

Via Chartmill

Thermo Fisher Scientific Deepens Investment in Asia’s Biopharma Ecosystem with Expansion of Bioprocess Design Centers

December 02, 2025

Thermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes

November 24, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

1 Cash-Producing Stock to Own for Decades and 2 Facing Headwinds

November 24, 2025

Agilent Technologies (NYSE: A) Declares Quarterly Dividend, Signaling Continued Shareholder Value

November 19, 2025

SANTA CLARA, CA – November 19, 2025 – Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced that its Board of Directors has...

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' ↗

Topics Artificial Intelligence Economy Regulatory Compliance

Institutions Love These 3 Companies, Should You As Well? ↗

November 19, 2025

Via MarketBeat

These 3 Stocks Are Using Buybacks to Signal Market Confidence ↗

November 18, 2025

Via MarketBeat

November 18, 2025

Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.

Via Benzinga

Topics ETFs

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Topics ETFs

Kimberly-Clark, Thermo Fisher Scientific, Berkshire Hathaway And An Industrial Stock On CNBC's 'Final Trades' ↗

November 14, 2025

Kimberly-Clark is still "oversold after the Kenvue announcement," Jenny Van Leeuwen Harrington says, citing its 5% dividend yield.

Via Benzinga

Thermo Fisher Scientific Receives 510(k) Clearance in the United States for EXENT System* to Aid in the Diagnosis of Multiple Myeloma

November 12, 2025

Thermo Fisher Scientific Reinforces Investor Confidence with Latest Quarterly Dividend Declaration

November 06, 2025

Waltham, MA – November 6, 2025 – Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in scientific instrumentation, laboratory services, and diagnostic solutions, today announced its latest...

Topics Artificial Intelligence Economy Retirement

Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases

November 06, 2025

Thermo Fisher Scientific Declares Quarterly Dividend

November 06, 2025

Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years ↗

November 04, 2025

Via Benzinga

Avantor Plummets 17.4% as Disappointing Q3 Results and Impairment Charge Rock Investor Confidence

October 29, 2025

Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied...

Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities ↗

Topics Artificial Intelligence Economy Supply Chain

How Is The Market Feeling About Thermo Fisher Scientific Inc? ↗

October 29, 2025

Via Benzinga

October 29, 2025

Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and digital drug development capabilities.

Via Benzinga

Thermo Fisher To Acquire Clario Holdings In A $9.4B Deal ↗

October 29, 2025

Thermo Fisher expects the acquisition to be immediately accretive to its adjusted operating margin.

Via Stocktwits

Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights

October 29, 2025